相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Early outcome and safety of bedaquiline-containing regimens for treatment of MDR- and XDR-TB in China: a multicentre study
M. Gao et al.
CLINICAL MICROBIOLOGY AND INFECTION (2021)
Genotypic Resistance of Pyrazinamide but Not Minimum Inhibitory Concentration Is Associated With Longer Time to Sputum Culture Conversion in Patients With Multidrug-resistant Tuberculosis
Johanna Kuhlin et al.
CLINICAL INFECTIOUS DISEASES (2021)
A highly effective and inexpensive standardized treatment of multidrug-resistant tuberculosis: a multicenter prospective study in China
Wenwen Sun et al.
BMC INFECTIOUS DISEASES (2021)
Pharmacokinetic Modeling, Simulation, and Development of a Limited Sampling Strategy of Cycloserine in Patients with Multidrug-/Extensively Drug-Resistant Tuberculosis
Ruben van der Galien et al.
CLINICAL PHARMACOKINETICS (2020)
Treatment of Highly Drug-Resistant Pulmonary Tuberculosis
Camus Nimmo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Clofazimine improves clinical outcomes in multidrug-resistant tuberculosis: a randomized controlled trial
H. Duan et al.
CLINICAL MICROBIOLOGY AND INFECTION (2019)
Cycloserine Population Pharmacokinetics and Pharmacodynamics in Patients with Tuberculosis
Wael A. Alghamdi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Drug Resistance Characteristics of Mycobacterium tuberculosis Isolates From Patients With Tuberculosis to 12 Antituberculous Drugs in China
Xiaocui Wu et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2019)
Predictors of poor treatment outcomes in multidrug-resistant tuberculosis patients: a retrospective cohort study
A. Javaid et al.
CLINICAL MICROBIOLOGY AND INFECTION (2018)
A high throughput methodology for susceptibility testing of Mycobacterium tuberculosis isolates
Tashmin Rampersad et al.
JOURNAL OF MICROBIOLOGICAL METHODS (2018)
Baseline resistance and cross-resistance among fluoroquinolones in multidrug-resistant Mycobacterium tuberculosis isolates at a national reference laboratory in India
H. G. Mamatha et al.
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE (2018)
Time to revise WHO-recommended definitions of MDR-TB treatment outcomes
Christoph Lange et al.
LANCET RESPIRATORY MEDICINE (2018)
Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study
Sergey E. Borisov et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
Isoniazid Resistance and Dosage as Treatment for Patients with Tuberculosis
Simone Nagel et al.
CURRENT DRUG METABOLISM (2017)
Outcomes of pulmonary MDR-TB: impacts of fluoroquinolone resistance and linezolid treatment
Byeong-Ho Jeong et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
Sensititre MYCOTB MIC Plate for Testing Mycobacterium tuberculosis Susceptibility to First- and Second-Line Drugs
Jongseok Lee et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Serum concentrations of cycloserine and outcome of multidrug-resistant tuberculosis in Northern Taiwan
W-Y. Hung et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2014)
Epidemiology of Isoniazid Resistance Mutations and Their Effect on Tuberculosis Treatment Outcomes
Mai N. T. Huyen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Clinical Benefit of Delamanid (OPC-67683) in the Treatment of Multidrug-Resistant Tuberculosis Patients in China
Qing Zhang et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2013)
Predictors of sputum culture conversion among patients treated for multidrug-resistant tuberculosis
E. V. Kurbatova et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2012)
WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update
D. Falzon et al.
EUROPEAN RESPIRATORY JOURNAL (2011)
Wild-Type MIC Distributions for Aminoglycoside and Cyclic Polypeptide Antibiotics Used for Treatment of Mycobacterium tuberculosis Infections
P. Jureen et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2010)
High Level of Cross-Resistance between Kanamycin, Amikacin, and Capreomycin among Mycobacterium tuberculosis Isolates from Georgia and a Close Relation with Mutations in the rrs Gene
Levan Jugheli et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)